Home All News Page 40

All News

Internet And Biotech Related News

Marijuana Stock Review, urban-gro

urban-gro (UGRO) $10.15 Marijuana’s First Fully Integrated Indoor Cultivation Powerhouse.

urban-gro announces its first major acquisition since raising $62 million in February and it's a doozey! The inclusion of architecture allows them to now...

Montana Based Drone Maker Skyfish Banks $20 Million.

American drone maker Skyfish secures over $20 million in Series Seed funding; appoints Cell Tower Industry Veteran Steven Bernstein to its Board of Directors MISSOULA, Mont.,...
ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine Efficacy.Launching Clinical...
Drone Stock Review

10 Best Drone Stocks to Invest In (InsiderMonkey).

In this article, we will look at the 10 best drone stocks to invest in based on the data of over 860 hedge funds...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold off launching...

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).

Summary: MAPS is featured in an article on the front page of today's edition of The New York Times! Reporter Andrew Jacobs profiles MAPS Founder and...
psychedelic stock review

Advances in Psychedelics can Change Investors’ Minds

Original article(s) on EXBulletin and Financial Times The science behind this subject has become mainstream in recent years. Excellent BBC documentary Psychedelic trial We explored the implications...

That’s it. $225 Million Raised by Atai (ATAI) Gets us Interested in the Psychedelics...

Redefining how the world approaches, prevents, and heals mental health disorders. LIVE QUOTE Initially founded as a holding group that later became involved in operations, Atai...
Provention

Teplizumab: Can We Delay the Onset of Type 1? (DiaTribe)

Teplizumab: Can We Delay the Onset of Type 1? Last updated: 6/7/21 By Dr. Francine Kaufman Provention Bio’s new injectable drug was recommended by an FDA committee...
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while significantly reducing...

Latest article

Jeffrey Gundlach: Reckoning is Coming.

Jeffrey Edward Gundlach is a businessman, fund manager, and philanthropist. He is the founder of DoubleLine Capital, an investment firm. On 11 November 2020, Gundlach remarked in an interview with...

Who’s the Next Eric Sprott?

Eric Sprott, on Who is the Next Eric Sprott! To say Eric Sprott has left a legendary mark on the world of mining investment would...

Perpetua (PPTA) Raises $300 Million.

Not a bad day in Idaho. $300 million banked! We look at the dip as a buying opportunity, as does John Paulson & Co.,...